Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin

被引:79
作者
Whisstock, JC
Pike, RN
Jin, L
Skinner, R
Pei, XY
Carrell, RW
Lesk, AM
机构
[1] Univ Cambridge, Sch Clin, Cambridge Inst Med Res, Wellcome Trust Ctr Mol Mech Dis, Cambridge CB2 2XY, England
[2] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3168, Australia
基金
英国惠康基金; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
protein structure comparison; mechanism of conformational change; proteinase inhibition; S -> R transition; heparin;
D O I
10.1006/jmbi.2000.3982
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antithrombin, uniquely among plasma serpins acting as proteinase inhibitors in the control of the blood coagulation cascade, circulates in a relatively inactive form. Its activation by heparin, and specifically by a pentasaccharide core of heparin, has been shown to involve release of the peptide loop containing the reactive centre from partial insertion in the A sheet of the molecule. Here we compare the structures of the circulating inactive form of antithrombin with the activated structure in complex with heparin pentasaccharide. We show that the rearrangement of the reactive centre loop that occurs upon activation is part of a widespread conformational change involving a realignment of the two major domains of the molecule. We also examine natural mutants that possess high affinity for heparin pentasaccharide, and relate the kinetics of their interaction with heparin pentasaccharide to the structural transitions occuring in the activation process. (C) 2000 Academic Press.
引用
收藏
页码:1287 / 1305
页数:19
相关论文
共 40 条
[1]   Antithrombins Wibble and Wobble (T85M/K): Archetypal conformational diseases with in vivo latent - Transition, thrombosis, and heparin activation [J].
Beauchamp, NJ ;
Pike, RN ;
Daly, M ;
Butler, L ;
Makris, M ;
Dafforn, TR ;
Zhou, A ;
Fitton, HL ;
Preston, FE ;
Peake, IR ;
Carrell, RW .
BLOOD, 1998, 92 (08) :2696-2706
[2]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[3]   THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP) [J].
BRUCE, D ;
PERRY, DJ ;
BORG, JY ;
CARRELL, RW ;
WARDELL, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2265-2274
[4]   ALPHA-1-ANTITRYPSIN AND THE SERPINS - VARIATION AND COUNTERVARIATION [J].
CARRELL, R ;
TRAVIS, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (01) :20-24
[5]   PLAKALBUMIN, ALPHA-1-ANTITRYPSIN, ANTITHROMBIN AND THE MECHANISM OF INFLAMMATORY THROMBOSIS [J].
CARRELL, RW ;
OWEN, MC .
NATURE, 1985, 317 (6039) :730-732
[6]   Conformational disease [J].
Carrell, RW ;
Lomas, DA .
LANCET, 1997, 350 (9071) :134-138
[7]   BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN [J].
CARRELL, RW ;
STEIN, PE ;
WARDELL, MR ;
FERMI, G .
STRUCTURE, 1994, 2 (04) :257-270
[8]   STRUCTURE-ACTIVITY RELATIONSHIP IN HEPARIN - A SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR ANTI-THROMBIN-III AND ELICITING HIGH ANTI-FACTOR-XA ACTIVITY [J].
CHOAY, J ;
PETITOU, M ;
LORMEAU, JC ;
SINAY, P ;
CASU, B ;
GATTI, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (02) :492-499
[9]  
DESAI U, 1999, 2 INT S STRUCT BIOL
[10]   Mechanism of heparin activation of antithrombin:: Evidence for an induced-fit model of allosteric activation involving two interaction subsites [J].
Desai, UR ;
Petitou, M ;
Björk, I ;
Olson, ST .
BIOCHEMISTRY, 1998, 37 (37) :13033-13041